Bicara Therapeutics Inc.
Q3 2026 13F Holders
Symbol
BCAX
CUSIP
055477103
Type
Equity
Class
COM
Num filings
4
Total reported value, excl. options
$37.9 k
Compare 2026 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type